CDMO0.00%14.3%
CRL+42.73%14.3%
DGX+21.35%14.3%
FTRE+235.29%14.3%
LH+9.46%14.3%
MRVI+106.57%14.3%
NOTV0.00%14.3%
As of Jul 10, 2026, 7:14 AM ET
MedTech Long '24: Lab Research & Trials Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics IncorporatedDGX | 14.3% | 2.14% | -0.08% | -2.16% | -3.69% | 19.89% | -1.82% | 24.48% | 21.35% | $23.03B |
Labcorp Holdings Inc.LH | 14.3% | -0.23% | -0.04% | -0.70% | -2.20% | 10.66% | -3.97% | 17.46% | 9.46% | $22.77B |
Charles River Laboratories International, Inc.CRL | 14.3% | 0.10% | 4.30% | 3.56% | 1.97% | 17.10% | 30.88% | 56.48% | 42.73% | $11.25B |
Fortrea Holdings Inc.FTRE | 14.3% | 0.00% | 3.82% | 0.86% | 0.51% | 2.43% | 64.83% | 135.29% | 235.29% | $1.67B |
Maravai LifeSciences Holdings, Inc.MRVI | 14.3% | 1.84% | 3.65% | -6.57% | -2.93% | 83.69% | 67.70% | 170.14% | 106.57% | $1.65B |
Inotiv, Inc.NOTV | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $553.0M |
Avid Bioservices, Inc.CDMO | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $361.4M |
| Theme return | — | 0.55% | 1.66% | -0.72% | -0.33% | 21.12% | 22.26% | 63.78% | 56.54% | — |
| Average | 14.3% | 0.55% | 1.66% | -0.72% | -0.91% | 19.11% | 22.52% | 57.69% | 59.34% | $8.75B |
| Median | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 10.66% | 0.00% | 24.48% | 21.35% | $1.67B |
| Std Dev | 0.0% | 0.92% | 1.96% | 2.88% | 1.91% | 27.40% | 29.78% | 63.30% | 79.68% | $9.60B |
| Min | 14.3% | -0.23% | -0.08% | -6.57% | -3.69% | 0.00% | -3.97% | 0.00% | 0.00% | $361.4M |
| Max | 14.3% | 2.14% | 4.30% | 3.56% | 1.97% | 83.69% | 67.70% | 170.14% | 235.29% | $23.03B |
| % Positive Tickers | 42.86% | 42.86% | 28.57% | 28.57% | 71.43% | 42.86% | 71.43% | 71.43% |
About this theme
MedTech Long '24: Lab Research & Trials tracks 7 publicly listed stocks in this theme: CDMO, CRL, DGX, FTRE, LH, MRVI, NOTV. See the constituent table for details.